天新药业(603235.SH)发布前三季度业绩，归母净利润4.6亿元，同比下降6.91%

Core Viewpoint - Tianxin Pharmaceutical (603235.SH) reported a slight revenue growth but a decline in net profit for the first three quarters of 2025 [1] Financial Performance - The company achieved a revenue of 1.631 billion yuan, representing a year-on-year increase of 1.08% [1] - The net profit attributable to shareholders was 460 million yuan, showing a year-on-year decrease of 6.91% [1] - The net profit after deducting non-recurring items was 431 million yuan, down 7.84% year-on-year [1] - Basic earnings per share stood at 1.06 yuan [1]